Qing Zhang

Dr. Qing Zhang


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
ZHZhinan Hao
Zhinan Hao
XTXiao-Ping Tan
Xiao-Ping Tan
QZQing Zhang
Qing Zhang
JLJie Li
Jie Li
RXRuohan Xia
Ruohan Xia
ZMZhaowu Ma
Zhaowu Ma
Lactate and its derivative, lactylation, play pivotal roles in modulating immune responses within the tumor microenvironment (TME), particularly in T-cell-mediated cancer immunotherapy. Elevated lactate levels, a hallmark of the Warburg effect, contribute to immune suppression through CD8+ T cell functionality and by promoting regulatory T cell (Treg) activity. Lactylation, a post-translational modification (PTM), alters histone and non-histone proteins, influencing gene expression and further reinforcing immune suppression. In the complex TME, lactate and its derivative, lactylation, are not only associated with immune suppression but can also, under certain conditions, exert immunostimulatory effects that enhance cytotoxic responses. This review describes the dual roles of lactate and lactylation in T-cell-mediated tumor immunity, analyzing how these factors contribute to immune evasion, therapeutic resistance, and immune activation. Furthermore, the article highlights emerging therapeutic strategies aimed at inhibiting lactate production or disrupting lactylation pathways to achieve a balanced regulation of these dual effects. These strategies offer new insights into overcoming tumor-induced immune suppression and hold the potential to improve the efficacy of cancer immunotherapies.

1 April 2008 in The International Journal of Biological Markers
Verified
Journal Article
Open access
QZQing Zhang
Qing Zhang
CHCm. Hu
Cm. Hu
YYY.S. Yuan
Y.S. Yuan
CHC.H. He
C.H. He
QZQ. Zhao
Q. Zhao
NLN.Z. Liu
N.Z. Liu
Aim: To study the expression of Mina53 and its relationships with clinicopathological characteristics, antioncogene inactivation and tumor proliferation in human gastric carcinoma, and to explore the role of Mina53 in carcinogenesis and tumor progression. Methods: Expression of Mina53 and proliferating cell nuclear antigen (PCNA) was determined in gastric carcinoma (n=79), gastric dysplasia (n=21) and normal gastric tissues (n=20), while p53 was measured in gastric carcinoma tissues by immunohistochemistry. Results: Mina53 was negatively expressed in all normal mucosa tissues. Dysplasia specimens showed weakly positive staining for Mina53 in 3 of 21 cases. Elevated expression of Mina53 was observed in 72 (91.1%) of the gastric carcinomas. No significant associations were found between Mina53 and clinicopathological characteristics such as sex, age, histological differentiation, distant metastasis and lymph node metastasis (p>0.05). There was a significant association with depth of invasion (χ2=5.385, p<0.05) and TMN stage (χ2=6.255, p<0.05). In gastric carcinoma, positive staining for p53 was detected in 53 of 79 cases (67.1%), showing a significant association with Mina53 (χ2=5.161, p<0.05). The mean (± SD) PCNA labeling index for gastric carcinoma was 39.47±16.92%. Mina53 expression was positively associated with PCNA level (r=0.756, p<0.01). Conclusion: Mina53 was overexpressed in gastric carcinoma and associated with tumor proliferation and antioncogene inactivation. Mina53 could therefore play an important role in the carcinogenesis and progression of gastric carcinoma.

5 December 2009 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
QZQing Zhang
Qing Zhang
XTXiao-Ping Tan
Xiao-Ping Tan
YYYue-Sha Yuan
Yue-Sha Yuan
CHCheng-Ming Hu
Cheng-Ming Hu
CHChang-Hua He
Chang-Hua He
NLNan-Zhi Liu
Nan-Zhi Liu

20 July 2018 in Chinese Medical Journal
Verified
Journal Article
Open access
PDF file
QZQing Zhang
Qing Zhang
JLJie Li
Jie Li
YLYi Li
Yi Li
CLCong-Han Lei
Cong-Han Lei
BSBai-Xue Shang
Bai-Xue Shang
XGXiao-Shuang Guan
Xiao-Shuang Guan
Chinese Medical Journal, China

1 July 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
SXSenping Xu
Senping Xu
ZJZiyang Jiang
Ziyang Jiang
QZQing Zhang
Qing Zhang
JGJiawei Guo
Jiawei Guo
Metabolic dysfunction-associated steatotic liver disease (MASLD) is initiated by ectopic lipid accumulation, but the precise mechanochemical transducers driving its progression to metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis remain incompletely understood. This review comprehensively elucidates the central pathogenic role of intracellular calcium signaling dysregulation in MASLD. We detail how the metabolically toxic microenvironment induces pathological biophysical remodeling of lipid rafts and key calcium transporters across the plasma membrane (PM), endoplasmic reticulum (ER), and mitochondria. This pervasive transmembrane and inter-organellar calcium imbalance precipitates severe organelle network collapse, characterized by calcium depletion-driven ER stress, mitochondrial dysfunction, and the structural derangement of mitochondria-associated ER membranes (MAMs). Aberrant calcium fluxes function as critical secondary messengers that dictate hepatic immune microenvironment remodeling, at the cellular level driving Kupffer cell pro-inflammatory polarization, NLRP3 inflammasome assembly, and the amplification of damage-associated molecular patterns (DAMPs). These calcium-dependent immune-metabolic feedback loops synergistically trigger hepatic stellate cell (HSC) transdifferentiation and fibrogenesis. Finally, we highlight the latent calcium-regulatory mechanisms of current metabolic therapeutics and prospect the translational potential of targeted calcium modulators coupled with advanced nanodelivery systems, advocating for multi-targeted pharmacological strategies to arrest irreversible liver injury.

1 January 2015 in World Chinese Journal of Digestology
Verified
Journal Article
Open access
XCXiao-Mei Cai
Xiao-Mei Cai
QZQing Zhang
Qing Zhang